Assessment of end-tidal carbon dioxide for endoscopic screening or therapy using carbon dioxide

Assessment of end-tidal carbon dioxide for endoscopic screening or therapy using carbon dioxide - Assessment of end-tidal carbon dioxide for endoscopic screening or therapy using carbon dioxide

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000012998

Enrollment

100

Registered

2014-02-03

Start date

2014-02-03

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with the necessity of receiving the routine endoscopic examination or endoscopic therapy

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients with the necessity of receiving the routine endoscopic examination or endoscopic therapy using CO2 2. Patients who participated oneself with enough understanding after receiving enough explanation

Exclusion criteria

Exclusion criteria: 1. Patients who have PaO2<60mmHg or PaCO2>45mmHg before routine endoscopic examination or endoscopic therapy using CO2 2. Patients with the coagulation disorder 3. Patients who are judged inappropriate by principal investigator or sub-investigator

Design outcomes

Primary

Measure	Time frame
the change of etCO2 before, under and after the routine endoscopic examination or endoscopic therapy	—

Secondary

Measure	Time frame
1. the change of arterial blood gas analysis before and after the routine endoscopic examination or endoscopic therapy 2. relationship between the respiratory function test and etCO2 3. relationship between arterial blood gas analysis and etCO2 before, under and after the routine endoscopic examination or endoscopic therapy 4. relationship between age and etCO2 before, under and after the routine endoscopic examination or endoscopic therapy 5. relationship between gender and etCO2 before, under and after the routine endoscopic examination or endoscopic therapy 6. relationship between height, weight, body mass index and etCO2 before, under and after the routine endoscopic examination or endoscopic therapy 7. relationship between past history, history of present illness, past herapy and etCO2 before, under and after the routine endoscopic examination or endoscopic therapy 8. relationship between blood pressure and etCO2 before, under and after the routine endoscopic examination or endoscopic therapy 9. adverse event by this study	—

Measure

Time frame

1. the change of arterial blood gas analysis before and after the routine endoscopic examination or endoscopic therapy 2. relationship between the respiratory function test and etCO2 3. relationship between arterial blood gas analysis and etCO2 before, under and after the routine endoscopic examination or endoscopic therapy 4. relationship between age and etCO2 before, under and after the routine endoscopic examination or endoscopic therapy 5. relationship between gender and etCO2 before, under and after the routine endoscopic examination or endoscopic therapy 6. relationship between height, weight, body mass index and etCO2 before, under and after the routine endoscopic examination or endoscopic therapy 7. relationship between past history, history of present illness, past herapy and etCO2 before, under and after the routine endoscopic examination or endoscopic therapy 8. relationship between blood pressure and etCO2 before, under and after the routine endoscopic examination or endoscopic therapy 9. adverse event by this study

—

Countries

Japan

Contacts

Public ContactNobuaki Azemoto

Ehime Prefectural Central Hospital Gastroenterology Center

azemotonobu@gmail.com089-947-1111

Outcome results